Leerink Partnrs Issues Negative Forecast for CRSP Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Equities researchers at Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics in a report released on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now expects that the company will earn ($1.35) per share for the quarter, down from […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Equities researchers at Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics in a report released on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now expects that the company will earn ($1.35) per share for the quarter, down from […]